NY Times: Study Says J&J Shot May Be Less Effective Against Delta Variant

Another potential setback for the Johnson & Johnson COVID-19 vaccine — a new study suggests the one-dose shot may be less effective at battling the delta variant than other vaccines, the New York Times reported. NBC 6’s Alyssa Hyman reports